Ignite Creation Date:
2024-07-17 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467604
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-11
Brief Title:
CRAVE Study Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
Sponsor:
University of California Davis
Organization:
University of California Davis
Study Overview
Official Title:
CRAVE Study Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess the impact of GLP-1 receptor agonists semaglutide and tirzepatide on food cravings and diet quality in individuals with overweight or obesity Over 24 weeks up to 150 adult participants will be monitored using questionnaires and dietary records at 0 12 and 24 weeks to measure changes in diet quality disordered eating food cravings and hunger This research conducted with Seen Medical Group at Knownwell Health Clinic seeks to fill the gap in literature on the dietary quality effects of GLP-1RAs
Detailed Description:
This study aims to evaluate the impact of GLP-1 receptor agonist GLP-1RA medications specifically semaglutide and tirzepatide on food cravings and diet quality among individuals diagnosed with overweight and obesity Participants will be recruited through Knownwell Health clinical staff who will refer eligible patients to the UCD research team for further information and screening
At Knownwell Clinic standard care for patients on GLP-1RA medications includes blood draws blood pressure evaluations body composition analysis Seca and indirect calorimetry testing These procedures will be conducted at baseline week 0 midpoint weeks 8-12 and end of titrationmax dose week 24
Participants will complete a series of virtual questionnaires on nutrition eating habits and diet quality along with a 3-day food diary Regular medical appointments will follow Knownwell Clinics standards of care Participants must procure their own GLP-1RA medication This study adds questionnaires to assess dietary quality photo-based food records hunger hunger VAS survey and food cravings FCI-II related to GLP-1RA use
At Knownwell Clinic standard care for patients on GLP-1RA medications includes blood draws blood pressure evaluations body composition analysis Seca and indirect calorimetry testing These procedures will be conducted at baseline week 0 midpoint weeks 8-12 and end of titrationmax dose week 24
Participants will complete a series of virtual questionnaires on nutrition eating habits and diet quality along with a 3-day food diary Regular medical appointments will follow Knownwell Clinics standards of care Participants must procure their own GLP-1RA medication This study adds questionnaires to assess dietary quality photo-based food records hunger hunger VAS survey and food cravings FCI-II related to GLP-1RA use
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None